Cite
Alba E, Lluch A, Ribelles N, et al. High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer. Oncologist. 2016;21(6):778doi: 10.1634/theoncologist.2015-0312erratum.
Alba, E., Lluch, A., Ribelles, N., Anton-Torres, A., Sanchez-Rovira, P., Albanell, J., Calvo, L., García-Asenjo, J. A., Palacios, J., Chacon, J. I., Ruiz, A., De la Haba-Rodriguez, J., Segui-Palmer, M. A., Cirauqui, B., Margeli, M., Plazaola, A., Barnadas, A., Casas, M., Caballero, R., Carrasco, E., & Rojo, F. (2016). High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer. The oncologist, 21(6), 778. https://doi.org/10.1634/theoncologist.2015-0312erratum
Alba, Emilio, et al. "High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer." The oncologist vol. 21,6 (2016): 778. doi: https://doi.org/10.1634/theoncologist.2015-0312erratum
Alba E, Lluch A, Ribelles N, Anton-Torres A, Sanchez-Rovira P, Albanell J, Calvo L, García-Asenjo JA, Palacios J, Chacon JI, Ruiz A, De la Haba-Rodriguez J, Segui-Palmer MA, Cirauqui B, Margeli M, Plazaola A, Barnadas A, Casas M, Caballero R, Carrasco E, Rojo F. High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer. Oncologist. 2016 Jun;21(6):778. doi: 10.1634/theoncologist.2015-0312erratum. PMID: 27317735; PMCID: PMC4912359.
Copy
Download .nbib